series-c-plus
Stage
2000
Founded
1
Investors
About
Aprogen is a biotechnology company specializing in the development of novel antibody therapeutics and biosimilars.
Explore Aprogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.